Get the Stockscreener App
1.81
0.56%
0.01
After Hours:
1.94
0.13
+7.18%
Shuttle Pharmaceuticals Holdings Inc stock is traded at $1.81, with a volume of 679.28K.
It is up +0.56% in the last 24 hours and up +13.12% over the past month.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.
See More
Previous Close:
$1.80
Open:
$1.84
24h Volume:
679.28K
Relative Volume:
2.19
Market Cap:
$2.90M
Revenue:
-
Net Income/Loss:
$-7.35M
P/E Ratio:
-3.9348
EPS:
-0.46
Net Cash Flow:
$-5.48M
1W Performance:
-3.21%
1M Performance:
+13.12%
6M Performance:
-54.41%
1Y Performance:
-91.49%
1-Day Range:
$1.775
$2.39
1-Week Range:
$1.62
$2.39
52-Week Range:
$1.26
$25.25
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
Name
Shuttle Pharmaceuticals Holdings Inc
Sector
Phone
(240) 403-4212
Address
401 PROFESSIONAL DRIVE, GAITHERSBURG
Compare SHPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SHPH
Shuttle Pharmaceuticals Holdings Inc
|
1.81 | 2.89M | 0 | -7.35M | -5.48M | -0.46 |
|
ZTS
Zoetis Inc
|
125.92 | 55.45B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.62 | 49.25B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.00 | 45.02B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.95 | 35.81B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
496.72 | 20.98B | 3.08B | 1.24B | 1.07B | 25.61 |
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Latest News
Shuttle Pharmaceuticals Accelerates Equity Payment in Asset Deal - The Globe and Mail
Shuttle Pharmaceuticals Holdings Signs First Amendment to Asset Purchase Agreement With 1542770 BC - TradingView — Track All Markets
Shuttle Pharmaceuticals (SHPH) discloses 19.99% stock issuance for asset payment - Stock Titan
RSI Suggests Rebound May Be Near in Best Agrolife LimitedSector Performance Review & Daily Tips From Top Market Analysts - earlytimes.in
Shuttle Pharmaceuticals Holdings Inc Stock Analysis and ForecastSupport Zone Identification & High Return Stock Ideas - earlytimes.in
What drives Shuttle Pharmaceuticals Holdings Inc stock priceTake Profit Strategies & Free Triple Digit Wealth Increase - earlytimes.in
Astec LifeSciences Limited Stages Intraday Comeback Trend ChangeVolatility Adjusted Trading & Rapid Capital Appreciation - earlytimes.in
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Shuttle Pharmaceuticals (NASDAQ:SHPH) Trading Down 6.3% – Time to Sell? - Defense World
How Shuttle Pharmaceuticals Holdings Inc. stock benefits from global expansion2025 Market Outlook & Accurate Buy Signal Notifications - Улправда
Will Shuttle Pharmaceuticals Holdings Inc. stock benefit from AI adoptionPortfolio Return Summary & Reliable Price Breakout Signals - Улправда
Can Shuttle Pharmaceuticals Holdings Inc. stock deliver strong Q4 earningsTrade Volume Report & Free Long-Term Investment Growth Plans - Улправда
How Shuttle Pharmaceuticals Holdings Inc. stock reacts to job market dataWall Street Watch & High Yield Equity Trading Tips - Улправда
Aug Spikes: Will Shuttle Pharmaceuticals Holdings Inc. stock benefit from infrastructure spendingEarnings Recap Summary & Reliable Price Breakout Alerts - Улправда
Shuttle Pharmaceuticals Completes Strategic Asset Acquisition - MSN
Patterns Watch: Will Shuttle Pharmaceuticals Holdings Inc. stock benefit from infrastructure spendingPortfolio Gains Summary & AI Based Buy/Sell Signal Reports - Улправда
Is Shuttle Pharmaceuticals Holdings Inc. stock a buy on dipsBuy Signal & Low Drawdown Investment Ideas - ulpravda.ru
A activityGDP Growth & Free Safe Capital Growth Stock Tips - DonanımHaber
How Shuttle Pharmaceuticals Holdings Inc. stock reacts to oil pricesOptions Play & AI Forecasted Stock Moves - Bölüm Sonu Canavarı
Can Shuttle Pharmaceuticals Holdings Inc. stock deliver consistent earnings growth2025 Buyback Activity & Precise Trade Entry Recommendations - Улправда
Trade Report: How Shuttle Pharmaceuticals Holdings Inc. stock benefits from tech adoptionJuly 2025 Review & Verified Trade Idea Suggestions - Улправда
Published on: 2025-12-19 03:09:15 - ulpravda.ru
Shuttle Pharmaceuticals’ Terminated Glioblastoma Trial: What Investors Need to Know Now - TipRanks
Shuttle Pharmaceuticals’ terminated glioblastoma trial: What investors need to know now - MSN
Shuttle Pharmaceuticals Raises $2.5 Million in Private Placement - MSN
Shuttle Pharmaceuticals (NASDAQ: SHPH) details 625,156-share resale registration - Stock Titan
Retail Surge: How Shuttle Pharmaceuticals Holdings Inc. stock benefits from global expansionEarnings Beat & Expert Approved Trade Ideas - moha.gov.vn
Published on: 2025-12-06 06:28:12 - moha.gov.vn
Shuttle Pharmaceuticals Holdings Inc. (SHPH) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Shuttle Pharmaceuticals Holdings Inc. stock gain from government policiesEarnings Summary Report & Verified High Yield Trade Plans - Newser
Why Shuttle Pharmaceuticals Holdings Inc. stock is favored by pension fundsJuly 2025 Volume & Free Technical Confirmation Trade Alerts - Newser
Shuttle Pharmaceuticals (SHPH) Stock Analysis Report | Financials & Insights - Benzinga
Shuttle Pharmaceuticals CFO Resigns, Interim CEO Steps In - The Globe and Mail
Shuttle Pharmaceuticals CFO resigns, interim CEO steps in as acting CFO By Investing.com - Investing.com UK
Shuttle Pharmaceuticals CFO resigns, interim CEO steps in as acting CFO - Investing.com
Shuttle Pharmaceuticals Holdings IncTimothy Lorber resigns as CFO of Shuttle PharmaceuticalsSEC filing - marketscreener.com
Shuttle Pharmaceuticals Announces CFO Resignation and Interim Appointment - TradingView
You might want to take a look at Shuttle Pharmaceuticals Holdings Inc (SHPH) now - Setenews
SHPH closes AI platform asset deal with capped stock consideration - Stock Titan
Shuttle Pharmaceuticals Faces Agreement Termination and Settlement - MSN
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) -12.6% in Normal Trading: Stock Slides Despite Recent Acquisition - Stocks Telegraph
Shuttle Pharmaceuticals acquires AI firm Molecule.ai for $8 million By Investing.com - Investing.com Australia
Why Does SHPH Stock Dip? - StocksToTrade
Stocks to Watch: Shuttle Pharma, Butterfly Network, Captivision - 富途牛牛
Shuttle Pharmaceuticals settles Theradex dispute and discontinues Ropidoxuridine trials - Investing.com
Shuttle Pharmaceuticals settles Theradex dispute and discontinues Ropidoxuridine trials By Investing.com - Investing.com UK
[8-K] Shuttle Pharmaceuticals Holdings, Inc. Reports Material Event | SHPH SEC FilingForm 8-K - Stock Titan
Shuttle Pharmaceuticals stock falls after closing Molecule.ai acquisition - Investing.com
Shuttle Pharmaceuticals stock falls after closing Molecule.ai acquisition By Investing.com - Investing.com South Africa
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.19%
0.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):